HOME > TOP STORIES
TOP STORIES
-
REGULATORY LDP to Set Up Project Team to Strengthen Pharma Sector, Eyes Proposal in May
February 22, 2021
-
ORGANIZATION PhRMA Japan Chief Urges Govt to Return to Pro-Innovation Path, Airs Grievances over Decision-Making on Off-Year Price Cuts
February 19, 2021
-
BUSINESS Mitsubishi Tanabe Accelerating Drug Discovery via Open Innovation, Early-Stage Data Sharing
February 18, 2021
-
REGULATORY Celgene’s CAR-T Liso-Cel Now in Line for Possible March Approval in Japan
February 18, 2021
-
REGULATORY Japan Launches COVID-19 Vaccination Program
February 18, 2021
-
BUSINESS Novo Training Its Sights on Oral Diabetes Market with Rybelsus, Not Switches from GLP-1 Injectables
February 17, 2021
-
REGULATORY COVID-19 Vaccine Being Rolled Out for 40,000 Healthcare Workers in Japan
February 17, 2021
-
BUSINESS Shionogi Pharma Set to Expand CDMO Biz with Continuous Manufacturing, Eyes 10 Billion Yen Sales in FY2024
February 17, 2021
-
REGULATORY 17 Firms Get Approval for Cymbalta Generics, June Listing Eyed
February 16, 2021
-
REGULATORY PMDA Review Report: Pfizer Vaccine’s Efficacy for Variants Not Gauged in Clinical Trials, Continued Info Collection Needed
February 16, 2021
-
BUSINESS Japan’s 1st Humira Biosimilar Hits Market
February 16, 2021
-
REGULATORY Japan Approves Pfizer’s COVID-19 Vaccine, Rollout Set for Mid Week
February 15, 2021
-
BUSINESS Japan Trial Now Underway for Gene Therapy Luxturna; Eyes Riveted on Its Price Tag
February 12, 2021
-
BUSINESS Kobayashi Kako Chief to Resign over Drug Mix-Up, Lousy Manufacturing and Cover-Ups
February 10, 2021
-
REGULATORY Kobayashi Kako Slapped with Record 116-Day Business Suspension
February 9, 2021
-
REGULATORY Pfizer’s COVID-19 Shot Up for PAFSC Review Feb. 12, Kono Expects Govt to Secure Enough Doses for 1st-in-Line HCPs
February 9, 2021
-
BUSINESS 7 Japan Drug Majors See 2.7% Revenue Fall in FY2020, COVID-19 Forces Cuts on Guidance: Jiho Tally
February 8, 2021
-
BUSINESS Health Minister Hails Domestic Production Plan for AstraZeneca Vaccine
February 8, 2021
-
BUSINESS AstraZeneca Files COVID-19 Vaccine in Japan
February 5, 2021
-
BUSINESS MSD to Launch Silgard 9 on Feb. 24, but Mass Supply in Japan Unlikely Until 2023
February 5, 2021
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
